Literature DB >> 2417036

Characterization of monoclonal antibodies to carcinoembryonic antigen with increased tumor specificity.

S Jothy, S A Brazinsky, M Chin-A-Loy, A Haggarty, M J Krantz, M Cheung, A Fuks.   

Abstract

Nine monoclonal antibodies reacting with carcinoembryonic antigen (CEA) were produced after immunization of mice with either purified CEA or a CEA-producing human cell line. Their specificities were assessed by immunohistochemistry on tissue sections of neoplastic and nonneoplastic lesions. These monoclonal antibodies have different patterns of tissue reactivity. Two of them, D14 and B18, were found to have a high degree of specificity for colonic carcinoma and did not react with formalin-fixed paraffin-embedded sections of normal colon with standardized staining conditions. Most cases of noncolonic adenocarcinomas and normal epithelial structures were not stained by these two monoclonal antibodies. The specificity of the monoclonal antibodies was further investigated immunochemically using intact, reduced, and alkylated or chemically fragmented CEA. Liquid phase radioimmunoassays and antibody competition immunoenzymatic assays confirmed that the antibodies recognize different epitopes of CEA. These data support the concept of CEA heterogeneity and the reactivity of the D14 and B18 monoclonal antibodies with colonic adenocarcinomas indicates that they are useful immunohistochemical probes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2417036

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  11 in total

Review 1.  Advances in the study of HLA-restricted epitope vaccines.

Authors:  Lingxiao Zhao; Min Zhang; Hua Cong
Journal:  Hum Vaccin Immunother       Date:  2013-08-16       Impact factor: 3.452

2.  D-14 monoclonal antibody to carcinoembryonic antigen: immunohistochemical analysis of formalin-fixed, paraffin-embedded human colorectal carcinoma, tumors of non-colorectal origin and normal tissues.

Authors:  Z P Pavelic; N J Petrelli; L Herrera; M M Vaughan; J S Paecock; L Pavelic
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

3.  Isolation and characterization of cDNA clones encoding the human carcinoembryonic antigen reveal a highly conserved repeating structure.

Authors:  W Zimmermann; B Ortlieb; R Friedrich; S von Kleist
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

Review 4.  Molecular chemotherapy for breast cancer.

Authors:  A Patterson; A L Harris
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

5.  Immunohistochemical study of colorectal adenocarcinomas and adenomas with antibodies against carcinoembryonic antigen (CEA), CA19-9, keratin, alpha-tubulin and secretory component (SC).

Authors:  T Taguchi; H Kijima; T Mitomi; R Y Osamura
Journal:  Gastroenterol Jpn       Date:  1991-06

6.  Autologous human B-cell immune response to pulmonary adenocarcinomatous polymorphic epithelial mucin.

Authors:  J Xiang; T Moyana; A Maksymiuk
Journal:  J Clin Immunol       Date:  1995-03       Impact factor: 8.317

7.  Increased serum concentrations of cholesterol and triglycerides in the progression of breast cancer.

Authors:  C C Zielinski; I Stuller; P Rausch; C Müller
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

Review 8.  Adhesion molecules and their role in cancer metastasis.

Authors:  R M Lafrenie; M R Buchanan; F W Orr
Journal:  Cell Biophys       Date:  1993 Aug-Dec

9.  Transcription of carcinoembryonic antigen in normal colon and colon carcinoma. In situ hybridization study and implication for a new in vivo functional model.

Authors:  S Jothy; S Y Yuan; K Shirota
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

10.  Expression of nonspecific cross-reacting antigen species in myeloid leukemic patients and healthy subjects.

Authors:  A Noworolska; A Harłozińska; F Buchegger; B Lawińska; R Richter
Journal:  Blut       Date:  1989-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.